Using components of the vitamin D pathway to prevent and treat colon cancer

Nutrition Reviews

Volumn 70, Issue 12, 2012, Pages 721-729

  Stubbins, Renee E ^a   Hakeem, Aisha ^a   Núñez, Nomelí P ^a  

^a The University of Texas at Austin   (United States)

Author keywords

Colon cancer; Vitamin D; Vitamin D receptor

Indexed keywords

1ALPHA,25 DIHYDROXYCHOLECALIFEROL; ACYLTRANSFERASE; BETA CATENIN; DICKKOPF 1 PROTEIN; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MESSENGER RNA; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL1; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; UVOMORULIN; VITAMIN D; WNT PROTEIN;

AMINO TERMINAL SEQUENCE; CELL DIFFERENTIATION; COLON CANCER; EPIGENETICS; GENE OVEREXPRESSION; HUMAN; MALIGNANT TRANSFORMATION; MILK; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW;

BETA CATENIN; CALCITRIOL; CELL LINE, TUMOR; COLONIC NEOPLASMS; DIET; DIETARY SUPPLEMENTS; HUMANS; RECEPTORS, CALCITRIOL; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84870541317     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2012.00522.x     Document Type: Review

References (75)

1. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nat Genet. 2003;33(Suppl):238-244.
2. th ed. Philadelphia: Lippincott Williams & Wilkins; 2008:1218-1232.
3. Rubinfeld B, Albert I, Porfiri E, etal. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 1996;272:1023-1026.
4. Behrens J, Jerchow B, Würtele M, etal. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science. 1998;280:596-599.
5. Kishida S, Yamamoto H, Ikeda S, etal. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem. 1998;273:10823-10826.
6. Powell S, Zilz N, Beazer-Barclay Y, etal. APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359:235-237.
7. Inomata M, Ochiai A, Akimoto S, etal. Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res. 1996;56:2213-2217.
8. Korinek V, Barker N, Morin P, etal. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997;275:1784-1787.
9. He T, Chan T, Vogelstein B, etal. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999;99:335-345.
10. Crawford H, Fingleton B, Rudolph-Owen L, etal. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene. 1999;18:2883-2891.
11. Mann B, Gelos M, Siedow A, etal. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A. 1999;96:1603-1608.
12. He T, Sparks A, Rago C, etal. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509-1512.
13. DeLuca H. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(Suppl 6):S1689-S1696.
14. Bouillon R. Vitamin D and human health [in French]. Presse Med. 2009;38:3-6.
15. Norman A, Mizwicki M, Norman D. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov. 2004;3:27-41.
16. Carlberg C. Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling. Eur J Biochem. 1995;231:517-527.
17. Freedman L. Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation. J Nutr. 1999;129(Suppl 2S):S581-S586.
18. Pálmer H, González-Sancho J, Espada J, etal. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001;154:369-387.
19. Vandewalle B, Adenis A, Hornez L, etal. 1, 25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues. Cancer Lett. 1994;86:67-73.
20. Peña C, García J, García V, etal. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas. Int J Cancer. 2006;119:2098-2104.
21. Larriba M, Valle N, Pálmer H, etal. The inhibition of Wnt/beta-catenin signalling by 1alpha, 25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells. Endocr Relat Cancer. 2007;14:141-151.
22. Larriba M, Martín-Villar E, García J, etal. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis. 2009;30:1459-1468.
23. Peña C, García J, Silva J, etal. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet. 2005;14:3361-3370.
24. Slattery M, Wolff R, Curtin K, etal. Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res. 2009;660:12-21.
25. Godman C, Joshi R, Tierney B, etal. HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol Ther. 2008;7:1570-1580.
26. Malinen M, Saramäki A, Ropponen A, etal. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha, 25-dihydroxyvitamin D3. Nucleic Acids Res. 2008;36:121-132.
27. Holick M. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008;3:1548-1554.
28. Hong SN, Kim JH, Choe WH, etal. Circulating vitamin D and colorectal adenoma in asymptomatic average-risk individuals who underwent first screening colonoscopy: a case-control study. Dig Dis Sci. 2012;57:753-763.
29. Ashktorab H, Nguza B, Fatemi M, etal. Case-control study of vitamin D, dickkopf homolog 1 (DKK1) gene methylation, VDR gene polymorphism and the risk of colon adenoma in African Americans. PLoS ONE. 2011;6:e25314.
30. Goss K, Groden J. Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol. 2000;18:1967-1979.
31. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol. 1995;7:619-627.
32. Gumbiner B. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996;84:345-357.
33. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994;1198:11-26.
34. Perl A, Wilgenbus P, Dahl U, etal. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998;392:190-193.
35. Morin P. beta-catenin signaling and cancer. Bioessays. 1999;21:1021-1030.
36. Mariadason J, Bordonaro M, Aslam F, etal. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res. 2001;61:3465-3471.
37. Thomas M, Tebbutt S, Williamson R. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut. 1992;33:1660-1663.
38. Aguilera O, Peña C, García J, etal. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha, 25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis. 2007;28:1877-1884.
39. Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol. 2003;129:199-221.
40. Cadigan K, Liu Y. Wnt signaling: complexity at the surface. J Cell Sci. 2006;119:395-402.
41. Bafico A, Liu G, Yaniv A, etal. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol. 2001;3:683-686.
42. Mao B, Wu W, Li Y, etal. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature. 2001;411:321-325.
43. González-Sancho J, Aguilera O, García J, etal. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene. 2005;24:1098-1103.
44. Aguilera O, Fraga M, Ballestar E, etal. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 2006;25:4116-4121.
45. Pendás-Franco N, García J, Peña C, etal. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha, 25-dihydroxyvitamin D3. Oncogene. 2008;27:4467-4477.
46. Zebedee Z, Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene. 2001;20:8317-8325.
47. Wilson J, Deed R, Inoue T, etal. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res. 2001;61:8803-8810.
48. Fernandez-Garcia N, Palmer H, Garcia M, etal. 1alpha, 25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene. 2005;24:6533-6544.
49. Pálmer H, Larriba M, García J, etal. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med. 2004;10:917-919.
50. Batlle E, Sancho E, Francí C, etal. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2:84-89.
51. Cano A, Pérez-Moreno M, Rodrigo I, etal. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76-83.
52. Grooteclaes M, Frisch S. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene. 2000;19:3823-3828.
53. Lazarova D, Bordonaro M, Sartorelli A. Transcriptional regulation of the vitamin D(3) receptor gene by ZEB. Cell Growth Differ. 2001;12:319-326.
54. Postigo A, Dean D. Differential expression and function of members of the zfh-1 family of zinc finger/homeodomain repressors. Proc Natl Acad Sci U S A. 2000;97:6391-6396.
55. Bannister A, Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 1996;384:641-643.
56. Ogryzko V, Schiltz R, Russanova V, etal. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 1996;87:953-959.
57. Postigo A, Dean D. ZEB represses transcription through interaction with the corepressor CtBP. Proc Natl Acad Sci U S A. 1999;96:6683-6688.
58. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415-428.
59. Elloul S, Elstrand M, Nesland J, etal. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer. 2005;103:1631-1643.
60. Bird A. Perceptions of epigenetics. Nature. 2007;447:396-398.
61. Markowitz S, Bertagnolli M. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449-2460.
62. Marks P, Dokmanovic M. Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin Investig Drugs. 2005;14:1497-1511.
63. Thiagalingam S, Cheng K, Lee H, etal. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci. 2003;983:84-100.
64. Patra S, Patra A, Dahiya R. Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem Biophys Res Commun. 2001;287:705-713.
65. Gaschott T, Werz O, Steinmeyer A, etal. Butyrate-induced differentiation of Caco-2 cells is mediated by vitamin D receptor. Biochem Biophys Res Commun. 2001;288:690-696.
66. Garland C, Comstock G, Garland F, etal. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;2:1176-1178.
67. Tangrea J, Helzlsouer K, Pietinen P, etal. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control. 1997;8:615-625.
68. Feskanich D, Ma J, Fuchs C, etal. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13:1502-1508.
69. Yetley E. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88:S558-S564.
70. Gorham E, Garland C, Garland F, etal. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 2007;32:210-216.
71. Freedman D, Looker A, Chang S, etal. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2007;99:1594-1602.
72. Garland C, Gorham E, Mohr S, etal. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19:468-483.
73. Garland C, Gorham E, Mohr S, etal. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007;103:708-711.
74. Storey M, Forshee R, Anderson P. Beverage consumption in the US population. J Am Diet Assoc. 2006;106:1992-2000.
75. Cho E, Smith-Warner S, Spiegelman D, etal. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst. 2004;96:1015-1022.